Attached files
| file | filename |
|---|---|
| EX-32.1 - SECTION 906 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Trius Therapeutics Inc | d243173dex321.htm |
| EX-10.1 - COLLABORATION AND LICENSE AGREEMENT - Trius Therapeutics Inc | d243173dex101.htm |
| EX-10.2 - AMENDED AND RESTATED 2010 NON-EMPLOYEE DIRECTOR'S STOCK OPTION PLAN - Trius Therapeutics Inc | d243173dex102.htm |
| EX-31.2 - SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - Trius Therapeutics Inc | d243173dex312.htm |
| EX-31.1 - SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - Trius Therapeutics Inc | d243173dex311.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Trius Therapeutics Inc | Financial_Report.xls |
| 10-Q - FORM 10-Q - Trius Therapeutics Inc | d243173d10q.htm |
| EX-10.3 - TRIUS THERAPEUTICS, INC. SEVERANCE BENEFIT PLAN - Trius Therapeutics Inc | d243173dex103.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Trius Therapeutics, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John P. Schmid, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /s/ JOHN P. SCHMID |
| John P. Schmid |
| Chief Financial Officer (Principal Financial Officer) |
November 10, 2011
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.